Site logo
Site logo
Site logo
  • Learn
    • COVID-19
    • Congressional Biomedical Research Caucus Briefings
      • Caucus Briefing Calendar
      • About the CBRC
      • Caucus Members
    • Facilities and Administrative Costs: What Scientists Need to Know
    • News & Updates
    • Events
    • Research Funding Facts
    • Congressional Testimony
    • Beyond 2020: A Vision and Pathway for NIH Report
  • Advocate
    • Support Pro-Science Candidates in National, State, and Local Elections
    • Take Action
    • Advocacy Tips
      • An Introduction to Science Public Policy
      • Ideas for Advocacy
      • Presentation Best Practices
      • Communicating with Congress
        • NIH and NSF Talking Points
      • Communicating with the Media
        • Writing a Letter to the Editor
      • Finding Community Allies
    • Be An Advocate
    • Rally for Medical Research
    • Letters to Congress
  • About CLS
    • About Us
    • Director
    • Board of Directors
    • CLS History
    • Member Organizations
  • Contact Us
  • Donate

and Cancer: Update on Genetic Risk for Childhood Cancer and What We Can Do About It

CBRC Briefing Elephants, Dogs, and Cancer: Update on Genetic Risk for Childhood Cancer and What We Can Do About It
September 27, 2017in CBRC Briefing 0 Comments 0 Likes

Elephants, Dogs, and Cancer: Update on Genetic Risk for Childhood Cancer and What We Can Do About It

There is hardly a worse diagnosis for parents to receive than “your child has cancer.” What may be even worse is if one’s other children are also diagnosed with cancer.

Join the CLS

Join our grassroots network and receive alerts about important news and events.

Sign Up

Image module

6120 Executive Blvd.,
Suite 750
Rockville, MD 20852
T 301 347.9309
F 301 347.9310

CLS Member Organizations

Image module
Image module
Image module
Image module
Image module
Image module
Image module
Image module
Image module
div#stuning-header .dfd-stuning-header-bg-container {background-color: #0067ac;background-size: cover;background-position: center center;background-attachment: scroll;background-repeat: no-repeat;}#stuning-header div.page-title-inner {min-height: 260px;}#main-content .dfd-content-wrap {margin: -10px;} #main-content .dfd-content-wrap > article {padding: 10px;}@media only screen and (min-width: 1101px) {#layout.dfd-portfolio-loop > .row.full-width > .blog-section.no-sidebars,#layout.dfd-gallery-loop > .row.full-width > .blog-section.no-sidebars {padding: 0 20px;}#layout.dfd-portfolio-loop > .row.full-width > .blog-section.no-sidebars > #main-content > .dfd-content-wrap:first-child,#layout.dfd-gallery-loop > .row.full-width > .blog-section.no-sidebars > #main-content > .dfd-content-wrap:first-child {border-top: 20px solid transparent; border-bottom: 10px solid transparent;}#layout.dfd-portfolio-loop > .row.full-width #right-sidebar,#layout.dfd-gallery-loop > .row.full-width #right-sidebar {padding-top: 10px;padding-bottom: 10px;}#layout.dfd-portfolio-loop > .row.full-width > .blog-section.no-sidebars .sort-panel,#layout.dfd-gallery-loop > .row.full-width > .blog-section.no-sidebars .sort-panel {margin-left: -20px;margin-right: -20px;}}#layout .dfd-content-wrap.layout-side-image,#layout > .row.full-width .dfd-content-wrap.layout-side-image {margin-left: 0;margin-right: 0;}